AUY922 Completed Phase 1 Trials for Advanced Solid Tumors Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01132625Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan